BI-1206

· BioInvent International AB

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BI-1206, covering 2021-07-08 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]